Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Oryza Pharmaceuticals Logo
Oryza Pharmaceuticals Growth Score
60
CB Rank
115392
Heat Score
65
Oryza Pharmaceuticals is a developer, manufacturer, marketing, distributor, and seller of pharmaceutical products.
Founded
obfuscation
PrivateSeries B Shenzhen, Guangdong, China11-50 www.oryzapharma.com.cn/
Manufacturing
Marketing
Pharmaceutical
Retail
Overview

Oryza Pharmaceuticals
Total Funding
obfuscation
Growth Score
60
Heat Score
65

Total Funding
obfuscation
obfuscation
Series B raised
obfuscation
Growth Score60
-4 pts
in past quarter
Heat Score 65
0 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Events
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Oryza Pharmaceuticals

CB Rank
115392
Oryza Pharmaceuticals is a developer, manufacturer, marketing, distributor, and seller of pharmaceutical products.
Founded
obfuscation
PrivateSeries B Shenzhen, Guangdong, China11-50 www.oryzapharma.com.cn/
Manufacturing
Marketing
Pharmaceutical
Retail

Funding Rounds

Series B
OBF
in
obfuscation
Seed
OBF
in
obfuscation

Details

Legal Name Oryza Pharmaceuticals, Inc.
Also Known As Ruihua Pharmaceutical, 瑞华制药, Shenzhen Ruihua Pharmaceutical Technology Co., Ltd., 深圳市瑞华制药技术有限公司
Operating Status Active
Company Type For Profit
About the Company
Oryza Pharmaceuticals is a developer, manufacturer, marketing, distributor, and seller of pharmaceutical products.
Phone Number (954) 881-5481
Contact Email info@oryzapharma.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Sustained Release Oral Drug Delivery Technology Platform
A technology platform for developing oral drugs with controlled, sustained, delayed, or targeted release profiles.
Transdermal Patch Controlled Release Technology Platform
A technology platform for creating transdermal patches that deliver drugs through the skin with controlled release.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series B - Oryza Pharmaceuticals Logo
Series B - Oryza Pharmaceuticals
1
obfuscation
Feixi Industrial InvestmentSeries B
obfuscation
Series B - Oryza Pharmaceuticals Logo
Series B - Oryza Pharmaceuticals
1
obfuscation
Feixi Industrial InvestmentSeries B
obfuscation
Series B - Oryza Pharmaceuticals Logo
Series B - Oryza Pharmaceuticals
1
obfuscation
Feixi Industrial InvestmentSeries B
obfuscation
Series B - Oryza Pharmaceuticals Logo
Series B - Oryza Pharmaceuticals
1
obfuscation
Feixi Industrial InvestmentSeries B
obfuscation
Series B - Oryza Pharmaceuticals Logo
Series B - Oryza Pharmaceuticals
1
obfuscation
Feixi Industrial InvestmentSeries B

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Series B - Oryza Pharmaceuticals Logo
Series B - Oryza Pharmaceuticals
1
obfuscation
Feixi Industrial InvestmentSeries B
obfuscation
Series B - Oryza Pharmaceuticals Logo
Series B - Oryza Pharmaceuticals
1
obfuscation
Feixi Industrial InvestmentSeries B
obfuscation
Series B - Oryza Pharmaceuticals Logo
Series B - Oryza Pharmaceuticals
1
obfuscation
Feixi Industrial InvestmentSeries B
obfuscation
Series B - Oryza Pharmaceuticals Logo
Series B - Oryza Pharmaceuticals
1
obfuscation
Feixi Industrial InvestmentSeries B
obfuscation
Series B - Oryza Pharmaceuticals Logo
Series B - Oryza Pharmaceuticals
1
obfuscation
Feixi Industrial InvestmentSeries B

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Contacts 2
News
Technology
View Tech Report

Monthly Web Visits

80

IT Spend

$8.8MThis year, Oryza Pharmaceuticals is projected to spend $8.8M on IT, according to Aberdeen.

Active Website Tech Count

7Oryza Pharmaceuticals is actively using 7 technologies for its website, according to BuiltWith. These include IPhone / Mobile Compatible, Mobile Non Scaleable Content, and  OpenResty.
Sub-Organizations
Frequently Asked Questions

Where is Oryza Pharmaceuticals's headquarters? Oryza Pharmaceuticals is located in Shenzhen, Guangdong, China.Who invested in Oryza Pharmaceuticals? Oryza Pharmaceuticals has 2 investors including Feixi Industrial Investment and  ASBV.When was the last funding round for Oryza Pharmaceuticals? Oryza Pharmaceuticals closed its last funding round on
obfuscation
from a Series B round.Who are Oryza Pharmaceuticals's competitors? Alternatives and possible competitors to Oryza Pharmaceuticals may include Helus Pharma, Triastek, and  Remy Biosciences.How much funding has Oryza Pharmaceuticals raised to date? Oryza Pharmaceuticals has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(c8221c2 1)
|